A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.

Inclusion Criteria:

-Patients scheduled for LASIK surgery in both eyes.

Exclusion Criteria:

• Any systemic medication use within 3 months of screening (including over the counter, herbal, prescription, or nutritional supplement) which may affect dry eye or vision
• Use of topical eye medication other than prescribed for use in pre- or post-operative care
• Use of RESTASIS® or other topical ophthalmic cyclosporine product within 6 months prior to Screening
• Eye infection, inflammation, or allergy
• Soft contact lenses in the previous 7 days or rigid contact lenses in the previous 30 days prior to LASIK surgery.